Antibody microarrays as tools for biomarker discovery

Area of Science:

• Proteomics
• Biomarker Discovery
• Cancer Research

Background:

• Molecular profiling via high-throughput methods is advancing cancer biomarker identification.
• Targeted antibody arrays are key tools for discovering protein cancer biomarker candidates and conducting proteomic analyses.

Purpose of the Study:

• To review innovative strategies for cancer biomarker discovery using antibody arrays.
• To highlight current cancer biomarker candidates and their potential clinical applications.

Main Methods:

• Utilizing high-throughput molecular profiling techniques.
• Employing targeted antibody arrays for protein measurements in various biological samples (cells, tissues, body fluids).
• Integrating appropriate validation approaches for biomarker candidates.

Main Results:

• Antibody arrays facilitate the identification of protein cancer biomarker candidates.
• Novel strategies enable multiplexed protein measurements for biomarker discovery.
• Identified candidates require extensive validation for clinical utility.

Conclusions:

• Antibody array technology is crucial for discovering novel cancer-associated biomarkers.
• Validated biomarkers can support cancer diagnosis, surveillance, prognosis, and therapeutic strategies.
• Further research and validation are essential for translating array-identified biomarkers into clinical practice.